These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17706533)

  • 21. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
    Uslu L; Donig J; Link M; Rosenberg J; Quon A; Daldrup-Link HE
    J Nucl Med; 2015 Feb; 56(2):274-86. PubMed ID: 25572088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography.
    Kostakoglu L; Goldsmith SJ
    Clin Lymphoma; 2000 Jun; 1(1):67-74; discussion 75-6. PubMed ID: 11707816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?
    Kostakoglu L; Goldsmith SJ
    Eur J Nucl Med; 2000 Oct; 27(10):1564-78. PubMed ID: 11083548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.
    Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
    Klose T; Leidl R; Buchmann I; Brambs HJ; Reske SN
    Eur J Nucl Med; 2000 Oct; 27(10):1457-64. PubMed ID: 11083533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of PET in lymphoma.
    Jhanwar YS; Straus DJ
    J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial staging of lymphoma with positron emission tomography and computed tomography.
    Hicks RJ; Mac Manus MP; Seymour JF
    Semin Nucl Med; 2005 Jul; 35(3):165-75. PubMed ID: 16098290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging: staging and evaluation of lymphoma using nuclear medicine.
    Divgi C
    Semin Oncol; 2005 Feb; 32(1 Suppl 1):S11-8. PubMed ID: 15786021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center.
    Imataki O; Tamai Y; Yokoe K; Furukawa T; Kawakami K
    Intern Med; 2009; 48(17):1509-13. PubMed ID: 19721294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of FDG-PET/CT in the management of lymphoma.
    Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
    Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
    Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
    Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
    Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
    Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET scans in the staging of lymphoma: current status.
    Friedberg JW; Chengazi V
    Oncologist; 2003; 8(5):438-47. PubMed ID: 14530496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience in using 18F-FDG PET in the staging and restaging of malignant lymphomas].
    Tlostanova MS; Tiutin LA; Ryzhkova DV; Il'in NV; Ivanova EI; Vinogradova IuN; Ivanova AA; Savchenko ON
    Vestn Rentgenol Radiol; 2008; (1):50-3. PubMed ID: 22187900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When should FDG-PET be used in the modern management of lymphoma?
    Barrington SF; Mikhaeel NG
    Br J Haematol; 2014 Feb; 164(3):315-28. PubMed ID: 24131306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.